Both peptides reduce pro-inflammatory cytokines (IL-6, TNF-) and support resolution of chronic inflammation
Before we get into those potential benefits, lets look at how BPC-157 might be exerting these effects
If a supplier insists on acetic acid reconstitution without a solubility justification, that is a product quality flag
And of course, try to limit sugar consumption. 2
FDA did not evaluate Crohns disease, celiac disease, or tendonitis under the vote question because the nomination lacked sufficient information and the agency did not identify suitable clinical studies in those populations
Both intermittent dosing schedules (injections on specific days) and continuous daily administration showed benefits, suggesting some flexibility in protocol design